We are live on ! Find out more
XTNT icon

Xtant Medical Holdings

16 hedge funds and large institutions have $45.7M invested in Xtant Medical Holdings in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

5.53% more ownership

Funds ownership: 84.77%90.3% (+5.5%)

0% more funds holding

Funds holding: 1616 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

26% less capital invested

Capital invested by funds: $61.9M → $45.7M (-$16.1M)

Holders
16
Holders Change
Holders Change %
0%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
4
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

XTNT Hedge Fund Activity: Q3 2018 in Review

16 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q3 2018, worth a combined $45.7M — down 26% from $61.9M a quarter earlier.

Fund positioning in XTNT was balanced in Q3 2018: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 3 trimmed.

The largest buyer was Telemetry Investments, opening a new position worth an estimated $3.88M. The largest seller was UBS Group, cutting an estimated $40.8K.

  • 16 institutional investors held Xtant Medical Holdings (XTNT) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $45.7M of Xtant Medical Holdings stock for Q3 2018, down 26% quarter-over-quarter.
  • 1 fund opened new Xtant Medical Holdings positions in Q3 2018 and 1 closed out, a net change of 0 holders.
  • The largest Xtant Medical Holdings buyer in Q3 2018 was Telemetry Investments, an estimated $3.88M added.
  • The largest Xtant Medical Holdings seller in Q3 2018 was UBS Group, an estimated $40.8K sold.

Based on aggregated 13F filings for Q3 2018.